Oracle (ORCL) is raising the stakes in its battle with Google (GOOGL) over Android. The fight between the two companies goes back to 2010, when Oracle first accused Google of copying parts of its operating system. Now, Oracle is raising the stakes as it looks to expand the ongoing copyright lawsuit to cover newer Android versions. Oracle alleges that Google's Android copies source code from its Java platform. In its proposed complaint, Oracle wants to include 40 major and minor Android releases comprised of six versions, saying they represent an ongoing infringement of copyright. Oracle has argued that the infringement has hurt the Java platform. Google on the other hand, says its use of the application program interfaces, or APIs, in question falls under the doctrine of fair use. TheStreet's Kurumi Fukushima reports in New York.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.